首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Challenges in Glycemic Control in Perioperative and Critically Ill Patients: Perioperative Blood Glucose Monitoring in the General Surgical Population
【2h】

Challenges in Glycemic Control in Perioperative and Critically Ill Patients: Perioperative Blood Glucose Monitoring in the General Surgical Population

机译:围手术期和重症患者血糖控制的挑战:普外科人群围手术期血糖监测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several studies have shown a relationship between poor outcome and uncontrolled blood glucose (BG) in cardiac, neurosurgical, critical care, and general surgical patients. A major study showed that tight glycemic control (80–110mg/dl) was related to increased mortality. Based on evidence from controlled studies, the American Diabetes Association, and the Society of Thoracic Surgeons, maintaining intraoperative BG levels in the 140–180 mg/dl range seems appropriate. Optimization of the patient's preoperative medications and the use of insulin infusions, as well as surgical and anesthetic technique, are important factors for achieving desirable perioperative BG control. Minimizing BG variability during surgery should be part of the glycemic control strategy. Advances in real-time glucose monitoring may soon benefit hospitalized diabetes and nondiabetes patients.
机译:几项研究表明,心脏,神经外科,重症监护和普通外科患者的不良结局与血糖(BG)失控之间存在关联。一项重大研究表明,严格的血糖控制(80-110mg / dl)与死亡率增加有关。根据对照研究,美国糖尿病协会和胸外科医师协会的证据,将术中BG维持在140-180 mg / dl范围似乎是适当的。病人术前药物的优化以及胰岛素输注的使用以及外科和麻醉技术,是实现理想的围手术期BG控制的重要因素。尽量减少手术期间BG的变异性应是血糖控制策略的一部分。实时葡萄糖监测的进展可能很快使住院的糖尿病和非糖尿病患者受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号